Serial noninvasive targeted imaging of peripheral angiogenesis: Validation and application of a semiautomated quantitative approach

Journal of Nuclear Medicine

Volumn 50, Issue 8, 2009, Pages 1356-1363

  Dobrucki, Lawrence W ^a   Dione, Donald P ^a   Kalinowski, Leszek ^b   Dione, Donna ^a   Mendizabal, Marivi ^c   Yu, Jun ^a   Papademetris, Xenophon ^a   Sessa, William C ^a   Sinusas, Albert J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c GE HEALTHCARE   (United Kingdom)

Author keywords

Micro CT; Micro SPECT; Molecular imaging; Peripheral angiogenesis

Indexed keywords

AH 111744; ARGINYLGLYCYLASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID TECHNETIUM TC99M; CD51 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NC 100692; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ACCURACY; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY LIGATION; ARTICLE; AUTOMATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMORAL ARTERY; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VALIDATION PROCESS;

ALGORITHMS; ANGIOGENIC PROTEINS; ANGIOGRAPHY; ANIMALS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INTEGRIN ALPHAV; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES, CYCLIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM;

EID: 68249153257     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.060822     Document Type: Article

References (16)

1. Yu J, deMuinck ED, Zhuang Z, et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci USA. 2005;102:10999-11004.
2. Cai W, Chen K, Mohamedali KA, et al. PET of vascular endothelial growth factor receptor expression. J Nucl Med. 2006;47:2048-2056.
3. 3-targeted imaging of lung cancer. Neoplasia. 2005;7:271-279.
4. 124I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography. Cancer Res. 2002;62:5912-5919.
5. 3 integrin after murine hindlimb ischemia. Circulation. 2005;111:3255-3260.
6. 123I-VEGF165): biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma. Q J Nucl Med Mol Imaging. 2004; 48:198-206.
7. Lu E, Wagner WR, Schellenberger U, et al. Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue. Circulation. 2003;108:97-103.
8. 99mTc- NC100692. J Nucl Med. 2006;47:1434-1439.
9. 99mTc-NC100692: a tracer for imaging vitronectin receptors associated with angiogenesis - a preclinical investigation. Nucl Med Biol. 2008;35:365-375.
10. Indrevoll B, Kindberg GM, Solbakken M, et al. NC-100717: a versatile RGD peptide scaffold for angiogenesis imaging. Bioorg Med Chem Lett. 2006;16: 6190-6193.
11. 18F-AH111585 in breast cancer patients. J Nucl Med. 2008;49:879-886.
12. Hua J, Bourke B, Song J, et al. Noninvasive detection of angiogenesis, with a technetium-99m labeled peptide targeted at alphavbeta3 integrin following hindlimb ischemia [abstract]. J Am Coll Cardiol. 2004;43:25A.
13. Dobrucki LW, Sinusas AJ. Molecular imaging: a new approach to nuclear cardiology. Q J Nucl Med Mol Imaging. 2005;49:106-115.
14. Dobrucki LW, Sinusas AJ. Molecular cardiovascular imaging. Curr Cardiol Rep. 2005;7:130-135.
15. Dobrucki LW, Sinusas AJ. Cardiovascular molecular imaging. Semin Nucl Med. 2005;35:73-81.
16. Sinusas AJ. Imaging of angiogenesis. J Nucl Cardiol. 2004;11:617-633.